...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith deal/rvx future/money?

That's a great "guess" so this is where Cencora comes in but what do they receive in return - what are the costs involved etc etc? 

 

"Cencora connects manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We help our partners bring their innovations to patients around the world, which translates to unparalleled access and impact at the center of health"

Share
New Message
Please login to post a reply